One-third of patients with PSA levels below 0.2 ng/mL after radical prostatectomy have recurrent disease identifiable by PSMA PET. More than one-third of patients with PSA levels less than 0.5 ng/mL ...

When most people think of the Caribbean, images of white sandy beaches, turquoise waters, and a laid-back lifestyle come to mind. But beneath the surface of this tropical paradise lies ...

From March to July 2019 just over 40 000 people from 69 primary care centres in the Midlands and the South of England were invited to take part in the study. Inclusion criteria included being assigned ...

Graham Dean is convinced he would not be here today to enjoy his retirement if he hadn't received an invitation through the post one day for a prostate cancer screening check.

Telix Pharmaceuticals Limited today announces that its prostate cancer PET[1] imaging agent Illuccix® (kit for the preparation of gallium-68 gozetotide injection) has been granted marketing ...

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that its prostate cancer PET[1] imaging agent Illuccix® ...

It could be an infection, enlargement or cancer. 1 in every 8 men will develop prostate cancer and those of African-Caribbean ...

A prostate cancer screening program involving participants in the top decile of risk according to a polygenic risk score ...